Mimouna et al. use functional and transcriptomic approaches in a mouse model of multiple sclerosis to show that a transcriptional coregulator, GRIP1, known for anti-inflammatory actions, promotes macrophage- and microglia-driven neuroinflammation but also mediates therapeutic efficacy of type I IFN. The gene discussed is GRIP1; the disease is multiple sclerosis.